Genitourinary Radiology: Page 30

Which modality works best for diagnosing kidney stones?
By Kate Madden Yee
Which modality works best for diagnosing kidney stone disease, also known as urolithiasis: digital tomosynthesis, ultrasound, or the current reference standard of multidetector CT? It depends, according to a study published online May 17 in the European Journal of Radiology.
May 23, 2018
2016 08 23 17 04 30 620 Kidney 400
Cancer death rates continue to decline in U.S.
By Brian Casey
The U.S. continues to see a decline in cancer mortality, according to the latest numbers published by the U.S. government on May 22 in Cancer. However, the figures also indicate a rising incidence of late-stage prostate cancer, possibly due to the decline in prostate-specific antigen screening.
May 21, 2018
2017 09 14 23 05 1167 Cancer Cell 400
Blue Earth promotes results for PET/CT agent
By AuntMinnie.com staff writers
Molecular imaging firm Blue Earth Diagnostics is touting results from an investigational clinical trial with its Axumin F-18 fluciclovine PET/CT radiopharmaceutical.
May 20, 2018
Bone scan software predicts prostate cancer survival
By Brian Casey
Researchers using automated software to assess bone scintigraphy scans of patients with metastatic prostate cancer found that the algorithm helped them predict which patients were more likely to survive, compared with manual methods of interpreting the scans, according to a May 17 paper in JAMA Oncology.
May 16, 2018
2016 10 04 11 38 34 158 Prostate 400
Fewer men opt for prostate cancer treatment
By AuntMinnie.com staff writers
A record number of U.S. veterans are taking a wait-and-see approach and bypassing immediate surgery or radiation therapy to treat their prostate cancer, according to research published online May 15 in the Journal of the American Medical Association.
May 16, 2018
Interventional radiology used for Melania Trump procedure
By Kate Madden Yee
Interventional radiology was used in a May 14 procedure to treat first lady Melania Trump for a benign kidney condition. The procedure went well and the first lady is recovering at Walter Reed National Military Medical Center in Bethesda, MD, according to the White House.
May 14, 2018
2018 05 15 16 37 7888 Trump Melania 20180515165119
Blue Earth expands PSMA-PET/CT imaging portfolio
By AuntMinnie.com staff writers
Molecular imaging firm Blue Earth Diagnostics has signed an agreement for exclusive rights to radiopharmaceutical technology firm Scintomic's "radiohybrid" prostate-specific membrane antigen (rhPSMA-7) imaging agent.
May 6, 2018
FDA OK's Exact Imaging's FusionVu
By AuntMinnie.com staff writers
Ultrasound technology developer Exact Imaging has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FusionVu application on the ExactVu microultrasound system.
May 2, 2018
Acertara teams with John Hopkins on focused US study
By AuntMinnie.com staff writers
Ultrasonic acoustic measurement and testing firm Acertara Acoustic Laboratories said it is collaborating with Johns Hopkins University in Baltimore to assess the utility of focused ultrasound for improving drug delivery to the bladder wall.
April 9, 2018
SonaCare HIFU prostate registry reaches milestone
By AuntMinnie.com staff writers
High-intensity focused ultrasound (HIFU) developer SonaCare Medical said it has now enrolled more than 100 U.S. prostate cancer patients in its High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) registry.
April 4, 2018
AIUM: Contrast US finds prostate cancer that MRI misses
By Kate Madden Yee
NEW YORK CITY - A new technique for imaging microbubble ultrasound contrast agents shows promise for identifying prostate cancer even in patients with a negative MRI, according to a presentation delivered at the American Institute of Ultrasound in Medicine (AIUM) meeting.
March 26, 2018
2017 09 07 22 12 4441 New York Statue Liberty 400
High-dose radiotherapy lowers prostate cancer recurrence
By AuntMinnie.com staff writers
Increasing the radiotherapy dose for prostate cancer patients reduced their likelihood of developing recurrent cancer and metastases, but it did not improve their odds of survival, according to the results of a large-scale trial published online March 15 in JAMA Oncology.
March 25, 2018
Previous Page
Page 30 of 93
Next Page